![Edward Brennan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Brennan
Plus aucun poste en cours
Fortune : 38 579 $ au 30/06/2026
Profil
Edward J.
Brennan was the founder of InClinica, Inc., founded in 2007, where the titles held included President & Chief Medical Officer from 2007 to 2016.
Current jobs include Director at SkinJect, Inc. since 2023 and Chief Scientific Officer & Head-R&D Program at Medicus Pharma Ltd. since 2024.
Former jobs include Independent Director at Solarvest BioEnergy, Inc. in 2020, Medical Director at Wyeth-Ayerst Research from 2000 to 2003, Medical Director at GlaxoSmithKline LLC from 2003 to 2007, and President-BioSciences Division at Quantum BioPharma Ltd. Education includes a doctorate from Temple University School of Medicine and an undergraduate degree from Philadelphia College of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,15% | 03/06/2026 | 86 500 ( 0,15% ) | 38 579 $ | 30/06/2026 |
Postes actifs de Edward Brennan
| Sociétés | Poste | Début |
|---|---|---|
Skinject, Inc.
 Skinject, Inc. Hospital/Nursing ManagementHealth Services Provides skin cancer treatment services | Directeur/Membre du Conseil | 18/10/2023 |
Anciens postes connus de Edward Brennan
| Sociétés | Poste | Fin |
|---|---|---|
| SOLARVEST BIOENERGY INC. | Directeur/Membre du Conseil | 25/11/2020 |
InClinica, Inc.
 InClinica, Inc. BiotechnologyHealth Technology Operates clinical research and development organizations | Fondateur | 01/01/2016 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Directeur Technique/Scientifique/R&D | 01/01/2007 |
Wyeth-Ayerst Research | Directeur Technique/Scientifique/R&D | 01/01/2003 |
| QUANTUM BIOPHARMA LTD. | Directeur Technique/Scientifique/R&D | - |
Formation de Edward Brennan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Solarvest BioEnergy, Inc.
 Solarvest BioEnergy, Inc. Alternative Power GenerationUtilities Provides proprietary technology for the first time enables algae to produce hydrogen | Utilities |
InClinica, Inc.
InClinica, Inc. BiotechnologyHealth Technology Operates clinical research and development organizations | Health Technology |
Wyeth-Ayerst Research | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philadelphia College of Pharmacy
 Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skinject, Inc.
Skinject, Inc. Hospital/Nursing ManagementHealth Services Provides skin cancer treatment services | Health Services |
FSD Pharma, Inc.
 FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
